AR-V7 – a novel predictive and prognostic biomarker: Individualized therapy for castration-resistant prostate cancer [AR-V7 – ein neuer prädiktiver und prognostischer Biomarker: Therapieindividualisierung beim kastrationsresistenten Prostatakarzinom]

被引：0
|
作者：
Oing C. [1 ]
von Amsberg G. [1 ]
Bokemeyer C. [1 ]
机构：
[1] II. Medizinische Klinik – Onkologie, Hämatologie und Stammzelltransplantation mit Sektion Pneumologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg
来源：
Der Onkologe | 2015年 / 21卷 / 9期
关键词：
D O I：
10.1007/s00761-015-3019-9
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：846 / 847
页数：1
相关论文
共 50 条
  • [41] DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7
    Sue Jin Moon
    Byong Chang Jeong
    Hwa Jin Kim
    Joung Eun Lim
    Ghee Young Kwon
    Jeong Hoon Kim
    Oncogene, 2018, 37 : 1326 - 1339
  • [42] An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants and AR-v7 in Castration-Resistant Prostate Cancer
    Bae, Tae Hyun
    Sung, Ki Woon
    Pham, Tri M.
    Najy, Abdo J.
    Zamiri, Alaleh
    Jang, Hyejeong
    Mun, Su Ran
    Kim, Seongho
    Kwon, Ha Kyoung
    Son, Yeon Sung
    Shi, Dongping
    Kregel, Steven
    Heath, Elisabeth I.
    Cher, Michael L.
    Kwon, Yong Tae
    Kim, Hyeong-Reh Choi
    CANCER RESEARCH, 2025, 85 (02) : 342 - 359
  • [43] Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13 Editorial Comment
    Atala, Anthony
    JOURNAL OF UROLOGY, 2019, 201 (03): : 446 - 447
  • [44] Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
    Kallio, Heini M. L.
    Hieta, Reija
    Latonen, Leena
    Brofeldt, Anniina
    Annala, Matti
    Kivinummi, Kati
    Tammela, Teuvo L.
    Nykter, Matti
    Isaacs, William B.
    Lilja, Hans G.
    Bova, G. Steven
    Visakorpi, Tapio
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 347 - 356
  • [45] Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
    Zhu, Yezi
    Sharp, Adam
    Anderson, Courtney M.
    Silberstein, John L.
    Taylor, Maritza
    Lu, Changxue
    Zhao, Pei
    De Marzo, Angelo M.
    Antonarakis, Emmanuel S.
    Wang, Mindy
    Wu, Xingyong
    Luo, Yuling
    Su, Nan
    Rodrigues, Daniel Nava
    Figueiredo, Ines
    Welti, Jonathan
    Park, Emily
    Ma, Xiao-Jun
    Coleman, Ilsa
    Morrissey, Colm
    Plymate, Stephen R.
    Nelson, Peter S.
    de Bono, Johann S.
    Luo, Jun
    EUROPEAN UROLOGY, 2018, 73 (05) : 727 - 735
  • [46] Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
    Kallio, Heini M.
    Hieta, Reija
    Brofeldt, Anniina
    Annala, Matti
    Kivinummi, Kati
    Tammela, Teuvo L.
    Nykter, Matti
    Isaacs, William B.
    Lilja, Hans G.
    Bova, G. Steven
    Visakorpi, Tapio
    CANCER RESEARCH, 2018, 78 (13)
  • [47] Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
    Heini M. L. Kallio
    Reija Hieta
    Leena Latonen
    Anniina Brofeldt
    Matti Annala
    Kati Kivinummi
    Teuvo L. Tammela
    Matti Nykter
    William B. Isaacs
    Hans G. Lilja
    G. Steven Bova
    Tapio Visakorpi
    British Journal of Cancer, 2018, 119 : 347 - 356
  • [48] Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC).
    Scher, Howard I.
    Graf, Ryon P.
    Schreiber, Nicole A.
    Winquist, Eric
    McLaughlin, Brigit
    Lu, David
    Orr, Sarah
    Fleisher, Martin
    Lowes, Lori
    Anderson, Amanda K. L.
    Wang, Yipeng
    Dittamore, Ryan Vance
    Allan, Alison L.
    Attard, Gerhardt
    Heller, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells
    Liu, Lei
    Lou, Ning
    Li, Xiang
    Xu, Guanghua
    Ruan, Hailong
    Xia, Wen
    Qiu, Bin
    Bao, Lin
    Yuan, Changfei
    Huang, Xinmian
    Wang, Keshan
    Cao, Qi
    Chen, Ke
    Yang, Hongmei
    Zhang, Xiaoping
    ONCOLOGY REPORTS, 2017, 37 (06) : 3651 - 3659
  • [50] Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer" (vol 2, pg 1441, 2016)
    Scher, H., I
    Lu, D.
    Schreiber, N. A.
    JAMA ONCOLOGY, 2016, 2 (11) : 1511 - 1511
12345